Skip to main content
. 2022 Jan 10;13(1):31. doi: 10.1038/s41419-021-04480-3

Fig. 1. Changes in PGC-1α, mitochondrial dynamics, and NLRP3 inflammasome pathway in TGF-β1-treated RTECs.

Fig. 1

A mRNA and B protein expression levels of PGC-1α were decreased in TGF-β1-treated RTECs. C mRNA expression of mitochondrial dynamic-related genes including Mfn, Tfam, and Drp1were altered in TGF-β1-treated RTECs. D mRNA and E protein expression levels of the NLRP3 inflammasome pathway were increased in TGF-β1-treated RTECs. F Concentrations of IL-1β and IL-18 assessed by ELISA were increased in TGF-β1-treated RTECs. G mRNA and H protein expression levels of fibrotic markers including fibronectin and collagen 1, and apoptotic cell death markers of Bax/bcl-2 and cleaved caspase-3 were increased in TGF-β1-treated RTECs. Note: *P < 0.05 vs. control. PGC-1α peroxisomal proliferator-γ coactivator-1α; NLRP3 NOD-like receptor family, pyrin domain-containing 3; ASC, apoptosis-associated speck-like protein containing a caspase recruitment domain; RTEC renal tubular epithelial cell; Mfn mitofusin; Tfam mitochondrial transcriptional factor A; Drp1 dynamin-related protein 1; ELISA enzyme-linked immunosorbent assay.